Literature DB >> 26685314

Hepatocytes as Immunological Agents.

Ian N Crispe1.   

Abstract

Hepatocytes are targeted for infection by a number of major human pathogens, including hepatitis B virus, hepatitis C virus, and malaria. However, hepatocytes are also immunological agents in their own right. In systemic immunity, they are central in the acute-phase response, which floods the circulation with defensive proteins during diverse stresses, including ischemia, physical trauma, and sepsis. Hepatocytes express a variety of innate immune receptors and, when challenged with pathogen- or damage-associated molecular patterns, can deliver cell-autonomous innate immune responses that may result in host defense or in immunopathology. Important human pathogens have evolved mechanisms to subvert these responses. Finally, hepatocytes talk directly to T cells, resulting in a bias toward immune tolerance.
Copyright © 2015 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26685314      PMCID: PMC4685720          DOI: 10.4049/jimmunol.1501668

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  55 in total

1.  Control of antiviral defenses through hepatitis C virus disruption of retinoic acid-inducible gene-I signaling.

Authors:  Eileen Foy; Kui Li; Rhea Sumpter; Yueh-Ming Loo; Cynthia L Johnson; Chunfu Wang; Penny Mar Fish; Mitsutoshi Yoneyama; Takashi Fujita; Stanley M Lemon; Michael Gale
Journal:  Proc Natl Acad Sci U S A       Date:  2005-02-14       Impact factor: 11.205

2.  Age-related immune clearance of hepatitis B virus infection requires the establishment of gut microbiota.

Authors:  Han-Hsuan Chou; Wei-Hung Chien; Li-Ling Wu; Chi-Hung Cheng; Chen-Han Chung; Jau-Haw Horng; Yen-Hsuan Ni; Hong-Tai Tseng; Dafei Wu; Xuemei Lu; Hurng-Yi Wang; Pei-Jer Chen; Ding-Shinn Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2015-02-02       Impact factor: 11.205

3.  Cross-presentation of antigen by diverse subsets of murine liver cells.

Authors:  Mohammad R Ebrahimkhani; Isaac Mohar; Ian N Crispe
Journal:  Hepatology       Date:  2011-10       Impact factor: 17.425

4.  Liver is the major source of elevated serum lipocalin-2 levels after bacterial infection or partial hepatectomy: a critical role for IL-6/STAT3.

Authors:  Ming-Jiang Xu; Dechun Feng; Hailong Wu; Hua Wang; Yvonne Chan; Jay Kolls; Niels Borregaard; Bo Porse; Thorsten Berger; Tak W Mak; Jack B Cowland; Xiaoni Kong; Bin Gao
Journal:  Hepatology       Date:  2015-02       Impact factor: 17.425

5.  Liver-infiltrating lymphocytes in chronic human hepatitis C virus infection display an exhausted phenotype with high levels of PD-1 and low levels of CD127 expression.

Authors:  Henry Radziewicz; Chris C Ibegbu; Marina L Fernandez; Kimberly A Workowski; Kamil Obideen; Mohammad Wehbi; Holly L Hanson; James P Steinberg; David Masopust; E John Wherry; John D Altman; Barry T Rouse; Gordon J Freeman; Rafi Ahmed; Arash Grakoui
Journal:  J Virol       Date:  2006-12-20       Impact factor: 5.103

6.  The hepatocyte growth factor regulates the synthesis of acute-phase proteins in human hepatocytes: divergent effect on interleukin-6-stimulated genes.

Authors:  M I Guillén; M J Gómez-Lechón; T Nakamura; J V Castell
Journal:  Hepatology       Date:  1996-06       Impact factor: 17.425

7.  Direct, help-independent priming of CD8+ T cells by adeno-associated virus-transduced hepatocytes.

Authors:  Sherry A Wuensch; Jessica Spahn; Ian N Crispe
Journal:  Hepatology       Date:  2010-09       Impact factor: 17.425

8.  Down-regulation of Toll-like receptor 7 expression in hepatitis-virus-related human hepatocellular carcinoma.

Authors:  Kai-Jen Lin; Tsun-Mei Lin; Chiou-Huey Wang; Hsiang-Chun Liu; Yen-Li Lin; Hock-Liew Eng
Journal:  Hum Pathol       Date:  2012-10-12       Impact factor: 3.466

9.  Independent, parallel pathways to CXCL10 induction in HCV-infected hepatocytes.

Authors:  Jessica Brownell; Jessica Wagoner; Erica S Lovelace; Derek Thirstrup; Isaac Mohar; Wesley Smith; Silvia Giugliano; Kui Li; I Nicholas Crispe; Hugo R Rosen; Stephen J Polyak
Journal:  J Hepatol       Date:  2013-06-12       Impact factor: 25.083

10.  Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability.

Authors:  P D Cani; S Possemiers; T Van de Wiele; Y Guiot; A Everard; O Rottier; L Geurts; D Naslain; A Neyrinck; D M Lambert; G G Muccioli; N M Delzenne
Journal:  Gut       Date:  2009-02-24       Impact factor: 23.059

View more
  37 in total

1.  Precision-cut human liver slice cultures as an immunological platform.

Authors:  Xia Wu; Jessica B Roberto; Allison Knupp; Heidi L Kenerson; Camtu D Truong; Sebastian Y Yuen; Katherine J Brempelis; Marianne Tuefferd; Antony Chen; Helen Horton; Raymond S Yeung; Ian N Crispe
Journal:  J Immunol Methods       Date:  2018-02-01       Impact factor: 2.303

Review 2.  Reinterpreting recent thymic emigrant function: defective or adaptive?

Authors:  Cody A Cunningham; Eric Y Helm; Pamela J Fink
Journal:  Curr Opin Immunol       Date:  2017-12-16       Impact factor: 7.486

3.  Stressed erythrophagocytosis induces immunosuppression during sepsis through heme-mediated STAT1 dysregulation.

Authors:  Tolani F Olonisakin; Tomeka Suber; Shekina Gonzalez-Ferrer; Zeyu Xiong; Hernán F Peñaloza; Rick van der Geest; Yuting Xiong; David O Osei-Hwedieh; Jesús Tejero; Matthew R Rosengart; Wendy M Mars; Daria Van Tyne; Andreas Perlegas; Samuel Brashears; Daniel B Kim-Shapiro; Mark T Gladwin; Michael A Bachman; Eldad A Hod; Claudette St Croix; Yulia Y Tyurina; Valerian E Kagan; Rama K Mallampalli; Anuradha Ray; Prabir Ray; Janet S Lee
Journal:  J Clin Invest       Date:  2021-01-04       Impact factor: 14.808

4.  Inhibition of IRAK4 kinase activity improves ethanol-induced liver injury in mice.

Authors:  Han Wang; Hao Zhou; Quanri Zhang; Kyle L Poulsen; Vanessa Taylor; Megan R McMullen; Doug Czarnecki; Dhweeja Dasarathy; Minjia Yu; Yun Liao; Daniela S Allende; Xing Chen; Lingzi Hong; Junjie Zhao; Jinbo Yang; Laura E Nagy; Xiaoxia Li
Journal:  J Hepatol       Date:  2020-07-16       Impact factor: 25.083

Review 5.  Murine Models of Hepatitis A Virus Infection.

Authors:  Asuka Hirai-Yuki; Jason K Whitmire; Michael Joyce; D Lorne Tyrrell; Stanley M Lemon
Journal:  Cold Spring Harb Perspect Med       Date:  2019-01-02       Impact factor: 6.915

Review 6.  Innate immunity in stem cell-derived hepatocytes.

Authors:  Lena Fischer; David C Hay; Cliona O'Farrelly
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2018-07-05       Impact factor: 6.237

Review 7.  Integrative Physiology of Pneumonia.

Authors:  Lee J Quinton; Allan J Walkey; Joseph P Mizgerd
Journal:  Physiol Rev       Date:  2018-07-01       Impact factor: 37.312

8.  Regulatory T cell control of systemic immunity and immunotherapy response in liver metastasis.

Authors:  James C Lee; Sadaf Mehdizadeh; Jennifer Smith; Arabella Young; Ilgiz A Mufazalov; Cody T Mowery; Adil Daud; Jeffrey A Bluestone
Journal:  Sci Immunol       Date:  2020-10-02

9.  Characterizing Patients with Recurrent Urinary Tract Infections in Vesicoureteral Reflux: A Pilot Study of the Urinary Proteome.

Authors:  Dijana Vitko; Patricia S Cho; Stephen A Kostel; Shannon E DiMartino; Lily D Cabour; Matthew A Migliozzi; Tanya Logvinenko; Peter G Warren; John W Froehlich; Richard S Lee
Journal:  Mol Cell Proteomics       Date:  2020-01-02       Impact factor: 5.911

10.  T cells protect against hepatitis A virus infection and limit infection-induced liver injury.

Authors:  Ichiro Misumi; Joseph E Mitchell; Makayla M Lund; John M Cullen; Stanley M Lemon; Jason K Whitmire
Journal:  J Hepatol       Date:  2021-07-29       Impact factor: 25.083

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.